Article
Molecular study of ABCB1 gene and its correlation with imatinib response in chronic myeloid leukemia.
Cancer chemotherapy and pharmacology - 1 Oct 2017
Ben Hassine Islem, Gharbi Hanene, Soltani Ismail, Ben Hadj Othman Hind, Farrah Ahlem, Amouri Hassiba, Teber Mouheb, Ghedira Hela, Ben Youssef Yosra, Safra Ines, Abbes Salem, Menif Samia
Abstract excerpt
PURPOSE: The introduction and success of imatinib mesylate have become a paradigm shift in chronic myeloid leukemia (CML) treatment. However, despite its high efficiency, resistance to imatinib has emerged as a significant problem, which may in part be caused by pharmacogenetic variability. Three single-nucleotide polymorphisms (C1236T, G2677T/A, C3435T) and/or mRNA expression changes of ABCB1 gene were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
